Sara Volpe
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 18, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.Alfredo Vozza, Sara Volpe, Carlo Custodero
|Nov 27, 2024
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.Sara Volpe, Alfredo Vozza, Giuseppe Lisco
|Feb 25, 2023
Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study.Paolo Basile, Andrea Igoren Guaricci, Giuseppina Piazzolla
|Nov 11, 2022
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.Sara Volpe, Giuseppe Lisco, Margherita Fanelli
|Jun 24, 2022
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study.Sara Volpe, Giuseppe Lisco, Davide Racaniello
Pageof 1
Frequent Collaborators
5 joint publications
Giuseppina Piazzolla
3 joint publications
Giuseppe Lisco
3 joint publications
Margherita Fanelli
3 joint publications
Alfredo Vozza
2 joint publications
Vincenzo Triggiani
1 joint publications
Rossella Donghia
1 joint publications
Lucilla Crudele
1 joint publications
Roberta Rinaldi
1 joint publications
Paolo Basile
1 joint publications
Andrea Igoren Guaricci
